Status:
COMPLETED
THE EFFECT OF HELICOBACTER PYLORI ERADICATION THERAPY TO GASTRIC WALL THICKNESS BEFORE THE LAPAROSCOPIC SLEEVE GASTRECTOMY
Lead Sponsor:
Fatih Sultan Mehmet Training and Research Hospital
Conditions:
Helicobacter Pylori Infection
Obesity, Morbid
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
Laparoscopic sleeve gastrectomy is one of the most popular bariatric surgery in the world. The most important complication about this surgery that the leakage from the stapler line because of the inco...
Detailed Description
All patients who will undergo to Laparoscopic sleeve gastrectomy have upper gastrointestinal system endoscopy before the surgery in our clinical routine. In our research some patients who has Helicoba...
Eligibility Criteria
Inclusion
- All patients who will undergo to LSG will have upper gastrointestinal system endoscopy before the surgery and positive HP results.
Exclusion
- Having allergy to the medications which use for the HP eradication therapy
- The patients who is incompatible for the HP eradication therapy
- The patients who decided to undergo to another bariatric surgery peroperatively
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2021
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT03757650
Start Date
October 1 2018
End Date
February 1 2021
Last Update
March 23 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fatih Sultan Mehmet Research and Training Hospital
Istanbul, Turkey (Türkiye), 34734